← Leaderboards
Robert Lippert
Kuda Therapeutics, Inc.
$2,050,000
Attributed
$2,050,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2022–23$2M$1.5M$1M$500K$0
'22
'23
Funding mix
By agency
NIH$2,050,000 · 1
By mechanism
R44$2,050,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Clinical Trials”
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Angee Greer · Ppd Development Lp$82,531,927
- Jessica Ellis · Technical Resources International, Inc.$46,538,640
- Jessica Holden · Technical Resources International, Inc.$37,843,443
- Suma Babu · Massachusetts General Hospital$36,168,406
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
Research focus
Clinical TrialsCytotoxicAdvanced DevelopmentAutophagocytosisCombined Modality TherapyCommercializationCancer BiologyApoptosisCancer ModelCandidate MarkerAnimalsCaspase InhibitorCell DeathBindingCellsCessation Of LifeCharacteristicsCheckpoint InhibitionChemotherapy And/Or RadiationClear Cell Renal Cell CarcinomaClinicClinical DevelopmentClinical ManagementDeferoxamine